VivArt-X is focussing on women’s health. Our lead indication will revolutionize breast reconstructive surgery in women who have undergone breast tissue removal after breast cancer diagnosis.  

1 in 7 women will develop breast cancer during her life. The impact of physical and emotional pain of postoperative breast cancer patients is correlated to the reconstruction strategy and recovery time. Therefore, there is an unmet need for a new breast reconstructive method so that surgeons can restore, reconstruct and regenerate breast tissue predictably with long term potential that contributes to an improved quality of breast cancer patient’s life. 

VivArt-X offers a revolutionary synthetic, degradable biomaterial to achieve excellent cell engraftment, which results in personalized breast reconstruction and ultimately regeneration.